Engineering Robust Microbial Factories for Sustainable Energy, Medicine, and High-Value Chemicals. Yeast species are the cornerstone of the modern bio-economy due to their eukaryotic complexity, stress tolerance, and established industrial scalability. CD Biosynsis offers comprehensive Yeast Synthetic Biology and Metabolic Engineering Services, integrating advanced multidisciplinary toolkits—from enzyme design and directed evolution to Pareto-optimal metabolic modeling. We transform versatile yeast hosts like Saccharomyces cerevisiae and Yarrowia lipolytica into precision "mini-factories" capable of producing next-generation biofuels, pharmaceutical intermediates, and bioactive materials.
Get a Technical QuoteOur platform leverages the latest breakthroughs in synthetic biology to rewire yeast metabolism for maximum carbon flux and industrial fitness. We focus on achieving commercially viable titers through systemic engineering.
| Service Tier | Technical Strategy | Primary Application | Standard Deliverables |
|---|---|---|---|
| Biofuel Engineering | Organelle compartmentalization & dCas9 | Ethanol, Butanol, & Advanced fuels | Optimized strains + Yield analysis |
| Growth-Coupled Overproduction | Pareto Optimal Metabolic Engineering | Nicotinic Acid & Pharma intermediates | Stable production strains + Growth data |
| Biomaterial Processing | Surface Display & Biotransformation | Hyaluronic Acid (HA) & Bioactives | Strains with verified catalytic activity |
| Enzyme Optimization | Directed evolution & Protein design | Eliminating metabolic bottlenecks | Kinetic data + Validated enzymes |
1. Metabolic Simulation
2. Precision Engineering
3. Directed Evolution
4. Pilot Characterization
Utilizing in silico modeling to identify genetic targets and predict the Pareto optimal balance for growth-coupled production.
Formal project proposal and Mutual NDA signing.
Implementing CRISPR/Cas9, dCas9, and multiplex integration to assemble pathways and silence competitive branches.
Application of organelle compartmentalization for improved flux control.
Subjecting engineered strains to directed evolution and enzyme design to overcome kinetic bottlenecks.
Enhancing substrate tolerance and catalytic efficiency of rate-limiting enzymes.
Characterizing strains under industrial-scale stress conditions, focusing on Titer, Yield, and Rate (TYR).
Final validation in bioreactor environments to ensure commercial viability and stable overproduction.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field.
Large-scale biofuel production requires extreme metabolic speed and resilience. By integrating protein directed evolution, enzyme design, and organelle compartmentalization, researchers engineered S. cerevisiae to reach record yields of ethanol and butanol. This multidisciplined approach ensures high productivity and tolerance during rigorous industrial fermentation cycles.
(Reference: Yeast synthetic biology advances biofuel production, 2021)
Engineering often faces a trade-off between growth and synthesis. Utilizing a Pareto-optimal strategy in Yarrowia lipolytica, technical benchmarks achieved the growth-coupled overproduction of nicotinic acid—a vital pharma and fragrance intermediate. This strategy significantly reduces production costs and enables "green manufacturing" through continuous synthesis.
(Reference: Pareto optimal metabolic engineering, 2022)
The efficacy of Hyaluronic Acid (HA) depends on its molecular weight. By engineering yeast to express hyaluronidase on the cell surface, researchers transformed yeast into a "bioprocessing factory." This platform enables the direct conversion of high-molecular-weight HA into low-molecular-weight HA, showcasing yeast’s capability for post-processing and bioactive material manufacturing.
(Reference: Metabolic engineering: Tools and applications, 2023)
Ready to engineer your customized yeast mini-factory?
Contact Us1. Why is growth-coupled production important for industrial chemicals?
Growth-coupling ensures that the product is synthesized continuously as the cell grows. This prevents the "metabolic shift" often seen in late-stage fermentation, maintaining production stability and preventing the loss of engineered traits over time.
2. Can you engineer non-conventional yeast species like Yarrowia lipolytica?
Absolutely. While S. cerevisiae is the standard, we specialize in non-conventional species like Yarrowia lipolytica for lipid-based chemicals and complex aromatics due to their high secretion capacity and unique metabolic flux.
3. What is the benefit of "Organelle Compartmentalization"?
By sequestering a synthetic pathway inside an organelle like the mitochondria, we can protect the cell from toxic intermediates and drastically increase reaction speeds by concentrating enzymes and substrates in a confined space.
4. How do you handle production bottlenecks in complex pathways?
We use a combination of dCas9-mediated regulation to fine-tune gene expression and directed evolution to improve the kinetics of rate-limiting enzymes, ensuring a smooth and efficient metabolic flow.
5. What is the typical development cycle for pathway optimization?
A standard comprehensive project—from network modeling and CRISPR assembly to Pareto optimization—typically takes 14 to 20 weeks, depending on the complexity of the synthetic pathways.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.